Gene Signatures Stratify Computed Tomography Screening Detected Lung Cancer in High-Risk Populations☆
暂无分享,去创建一个
U. Pastorino | G. Pelosi | M. Boeri | G. Sozzi | K. Gatter | F. Pezzella | L. Roz | Jiangting Hu | Dongxiao Liu | A. Marchiano
[1] C. la Vecchia,et al. Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] Ugo Pastorino,et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial , 2012, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[3] A. Dirksen,et al. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT , 2012, Thorax.
[4] C. Croce,et al. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer , 2011, Proceedings of the National Academy of Sciences.
[5] Lara J. Monteiro,et al. Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer. , 2009, Cancer research.
[6] F. Fazio,et al. Fluorodeoxyglucose Uptake Measured by Positron Emission Tomography and Standardized Uptake Value Predicts Long-Term Survival of CT Screening Detected Lung Cancer in Heavy Smokers , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[7] L. Bloom,et al. FN3: a new protein scaffold reaches the clinic. , 2009, Drug discovery today.
[8] Libing Song,et al. Astrocyte elevated gene-1 is a proliferation promoter in breast cancer via suppressing transcriptional factor FOXO1 , 2009, Oncogene.
[9] Armando Santoro,et al. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. , 2009, American journal of respiratory and critical care medicine.
[10] W. Nishio,et al. Expression and localization of FOXO1 in non-small cell lung cancer. , 2009, Oncology reports.
[11] J. Roman,et al. Stimulation of lung carcinoma cell growth by fibronectin-integrin signalling. , 2008, Molecular bioSystems.
[12] P. Bach. Is our natural-history model of lung cancer wrong? , 2008, The Lancet. Oncology.
[13] B. Comin-Anduix,et al. Detailed analysis of immunologic effects of the cytotoxic T lymphocyte-associated antigen 4-blocking monoclonal antibody tremelimumab in peripheral blood of patients with melanoma , 2008, Journal of Translational Medicine.
[14] P. Scardino,et al. Forkhead protein FKHR and its phosphorylated form p-FKHR in human prostate cancer. , 2007, Human pathology.
[15] J. Lin,et al. PDK-1/AKT pathway as a novel therapeutic target in rhabdomyosarcoma cells using OSU-03012 compound , 2007, British Journal of Cancer.
[16] J. Crowley,et al. The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[17] O. Miettinen,et al. Survival of patients with stage I lung cancer detected on CT screening. , 2006, The New England journal of medicine.
[18] E. Bergstralh,et al. Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis. , 2006, Journal of the National Cancer Institute.
[19] Takayuki Kosaka,et al. Expression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] J. Varakis,et al. ILK over‐expression in human colon cancer progression correlates with activation of β‐catenin, down‐regulation of E‐cadherin and activation of the Akt–FKHR pathway , 2006, The Journal of pathology.
[21] J. Testa,et al. Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions. , 2004, Carcinogenesis.
[22] U. Pastorino,et al. Lung Cancers Detected by Screening with Spiral Computed Tomography Have a Malignant Phenotype when Analyzed by cDNA Microarray , 2004, Clinical Cancer Research.
[23] J. Cheong,et al. Constitutive phosphorylation of FKHR transcription factor as a prognostic variable in acute myeloid leukemia. , 2003, Leukemia research.
[24] F. Fazio,et al. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results , 2003, The Lancet.
[25] Alfonso Bellacosa,et al. AKT plays a central role in tumorigenesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[26] G. Bepler,et al. Screening for lung cancer. , 2000, The New England journal of medicine.
[27] A. Harris,et al. Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer , 2000, The Journal of pathology.
[28] Kenneth M. Yamada,et al. Fibronectin and integrins in invasion and metastasis , 1995, Cancer and Metastasis Reviews.
[29] J. Mulshine,et al. Early detection of lung cancer. , 1993, Seminars in oncology.
[30] S. Horning,et al. The natural history of initially untreated low-grade non-Hodgkin's lymphomas. , 1984, The New England journal of medicine.
[31] B J Flehinger,et al. Screening for early lung cancer. Results of the Memorial Sloan-Kettering study in New York. , 1984, Chest.
[32] Andrew H. Beck,et al. Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression , 2015, Modern Pathology.
[33] Screening for lung cancer. Too many uncertainties, even for smokers. , 2014, Prescrire international.
[34] C. Gatsonis,et al. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .
[35] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[36] M. Basson. An intracellular signal pathway that regulates cancer cell adhesion in response to extracellular forces. , 2008, Cancer research.
[37] Douglas C McCrory,et al. Screening for lung cancer: a review of the current literature. , 2003, Chest.
[38] J Murtaugh,et al. Early detection. , 1999, Journal of the American Dental Association.